Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stratton

Showing results (251-260 of 525) with videos related to

Pageof 53
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1S Bevan, T Pal, C R Greenberg, et al.
British Journal of Cancer|August 1, 1989
Structural alterations of the RB1 gene in human soft tissue tumoursM R Stratton, S Williams, C Fisher, et al.
Journal of Molecular and Cellular Cardiology|October 20, 1999
The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in manS Adamopoulos, G J Kemp, C H Thompson, et al.
Oncogene|May 1, 1993
Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findingsR A Eeles, W Warren, G Knee, et al.
Metabolism: Clinical and Experimental|June 1, 1992
Effect of intensive endurance training on lipoprotein profiles in young and older menR S Schwartz, K C Cain, W P Shuman, et al.
Cancer Letters|May 23, 2001
Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breastJ G Stone, G Coleman, B Gusterson, et al.
Blood|October 6, 2005
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disordersLinda M Scott, Peter J Campbell, E Joanna Baxter, et al.
Neuromuscular Disorders : NMD|July 8, 2008
Exclusion of biglycan mutations in a cohort of patients with neuromuscular disordersRachel A Peat, Jozef Gécz, Justin R Fallon, et al.
British Journal of Cancer|January 24, 2009
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibitionC L Mahoney, B Choudhury, H Davies, et al.
Mutagenesis|October 8, 2015
The genome as a record of environmental exposureSerena Nik-Zainal, Jill E Kucab, Sandro Morganella, et al.
Pageof 53

Showing results (251-260 of 525) with videos related to

Sort By:
Pageof 53
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1S Bevan, T Pal, C R Greenberg, et al.
British Journal of Cancer|August 1, 1989
Structural alterations of the RB1 gene in human soft tissue tumoursM R Stratton, S Williams, C Fisher, et al.
Journal of Molecular and Cellular Cardiology|October 20, 1999
The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in manS Adamopoulos, G J Kemp, C H Thompson, et al.
Oncogene|May 1, 1993
Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findingsR A Eeles, W Warren, G Knee, et al.
Metabolism: Clinical and Experimental|June 1, 1992
Effect of intensive endurance training on lipoprotein profiles in young and older menR S Schwartz, K C Cain, W P Shuman, et al.
Cancer Letters|May 23, 2001
Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breastJ G Stone, G Coleman, B Gusterson, et al.
Blood|October 6, 2005
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disordersLinda M Scott, Peter J Campbell, E Joanna Baxter, et al.
Neuromuscular Disorders : NMD|July 8, 2008
Exclusion of biglycan mutations in a cohort of patients with neuromuscular disordersRachel A Peat, Jozef Gécz, Justin R Fallon, et al.
British Journal of Cancer|January 24, 2009
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibitionC L Mahoney, B Choudhury, H Davies, et al.
Mutagenesis|October 8, 2015
The genome as a record of environmental exposureSerena Nik-Zainal, Jill E Kucab, Sandro Morganella, et al.
Pageof 53